User profiles for Jadwiga A. Wedzicha

Jadwiga Wedzicha

National Heart and Lung Institute, Imperial College London
Verified email at imperial.ac.uk
Cited by 78547

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

…, R Stockley, J Vestbo, JA Wedzicha… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

[HTML][HTML] COPD exacerbations: defining their cause and prevention

JA Wedzicha, TAR Seemungal - The lancet, 2007 - thelancet.com
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic …

JV Lightowler, JA Wedzicha, MW Elliott, FSF Ram - Bmj, 2003 - bmj.com
Objectives: To determine the effectiveness of non-invasive positive pressure ventilation (NPPV)
in the management of respiratory failure secondary to acute exacerbation of chronic …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

…, R Stockley, J Vestbo, JA Wedzicha… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease

…, JC Bestall, DJ Jeffries, JA Wedzicha - American journal of …, 1998 - atsjournals.org
Exacerbations occur commonly in patients with moderate or severe chronic obstructive
pulmonary disease (COPD) but factors affecting their severity and frequency or effects on quality …

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

…, A Bhowmik, DJ Jeffries, JA Wedzicha - American journal of …, 2000 - atsjournals.org
Although exacerbations of chronic obstructive pulmonary disease (COPD) are associated
with symptomatic and physiological deterioration, little is known of the time course and …

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

…, DJ Jeffries, SL Johnston, JA Wedzicha - American journal of …, 2001 - atsjournals.org
The effects of respiratory viral infection on the time course of chronic obstructive pulmonary
disease (COPD) exacerbation were examined by monitoring changes in systemic …

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

JA Wedzicha, PMA Calverley… - American journal of …, 2008 - atsjournals.org
Rationale: Exacerbations are key drivers of morbidity and mortality in chronic obstructive
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …

[HTML][HTML] Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD

JA Wedzicha, D Banerji, KR Chapman… - … England Journal of …, 2016 - Mass Medical Soc
Background Most guidelines recommend either a long-acting beta-agonist (LABA) plus an
inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice …

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

…, TAR Seemungal, RJ Sapsford, JA Wedzicha - Thorax, 2000 - thorax.bmj.com
BACKGROUND Although it is presumed that exacerbations of chronic obstructive
pulmonary disease (COPD) are associated with increased airway inflammation, there is little …